Erdan Dong
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
-
- Receptor Mechanisms and Signaling 7
- Inflammasome and immune disorders 4
-
- Cardiac electrophysiology and arrhythmias 6
- Cardiac Fibrosis and Remodeling 6
- Co-authors
- Wenjie Tan (1 shared paper)Miao Zhang (1 shared paper)Xueting Yao (1 shared paper)Fei Ye (1 shared paper)Baoying Huang (1 shared paper)Haiyan Li (1 shared paper)Roujian Lu (1 shared paper)Peihua Niu (1 shared paper)
- Journals
- Science China Life Sciences (6 papers)Acta Pharmacologica Sinica (5 papers)Frontiers in Cardiovascular Medicine (3 papers)European Journal of Pharmacology (2 papers)The Innovation (2 papers)
- Partner nations
- ChinaUnited StatesRomania
In The Last Decade
Erdan Dong
58 papers receiving 2.5k citations
Erdan Dong's Hit Papers
Peers
Comparison fields: 5 of 137
- Infectious Diseases 1.4k
- Neurology 561
- Ophthalmology 159
- Cardiology and Cardiovascular Medicine 340
- Pharmacology 123
Countries citing papers authored by Erdan Dong
This map shows the geographic impact of Erdan Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erdan Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erdan Dong more than expected).
Fields of papers citing papers by Erdan Dong
This network shows the impact of papers produced by Erdan Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erdan Dong. The network helps show where Erdan Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Erdan Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hit paper breakdown → | 2020 | 1855 |
| 2 | 2000 | 67 | |
| 3 | 2021 | 53 | |
| 4 | 2006 | 52 | |
| 5 | The cardiac donor. | 1971 | 51 |
| 6 | 2000 | 43 | |
| 7 | 1998 | 40 | |
| 8 | 1999 | 26 | |
| 9 | 2022 | 26 | |
| 10 | 2021 | 25 | |
| 11 | 2020 | 23 | |
| 12 | 2021 | 22 | |
| 13 | 2023 | 22 | |
| 14 | 2020 | 22 | |
| 15 | 2021 | 22 | |
| 16 | 1999 | 20 | |
| 17 | Hypothermic preservation of the canine heart. | 1974 | 18 |
| 18 | 2023 | 17 | |
| 19 | 2022 | 14 | |
| 20 | Results of 54 cardiac transplants. | 1973 | 13 |
About Erdan Dong
Erdan Dong is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Surgery, Biomedical Engineering and Epidemiology, having authored 66 papers that have together received 2.6k indexed citations. Recurring topics across this work include Transplantation: Methods and Outcomes (12 papers), Organ Transplantation Techniques and Outcomes (10 papers), Receptor Mechanisms and Signaling (7 papers), Mechanical Circulatory Support Devices (7 papers), Cardiac electrophysiology and arrhythmias (6 papers), Cardiac Fibrosis and Remodeling (6 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Inflammasome and immune disorders (4 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Neurology (561 citations), Ophthalmology (159 citations), Cardiology and Cardiovascular Medicine (340 citations) and Pharmacology (123 citations). Erdan Dong has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Wenjie Tan, Miao Zhang, Xueting Yao, Fei Ye, Baoying Huang, Haiyan Li, Roujian Lu, Peihua Niu, Cheng Cui and Xu Liu. Their work appears in journals such as Science China Life Sciences, Acta Pharmacologica Sinica, Frontiers in Cardiovascular Medicine, European Journal of Pharmacology and The Innovation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.